Michele Emdin

Q: What Schools Are Affiliated With Michele Emdin

Michele Emdin is affiliated with the following schools: Consorzio ICoN, University of Milan, University of Washington, Sant'Anna School of Advanced Studies, University of Florence

Michele Emdin's AcademicInfluence.com Rankings

Michele Emdin

Medical

#2106

World Rank

#2506

Historical Rank

Cardiology

#184

World Rank

#189

Historical Rank

medical Degrees

Michele Emdin

Philosophy

#6206

World Rank

#9204

Historical Rank

Logic

#3392

World Rank

#4541

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Michele Emdin's Degrees

Doctorate Medicine University of Florence
PhD Cardiology University of Florence

Why Is Michele Emdin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michele Emdin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. (2008) (366)
Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. (2004) (362)
The European ST-T database: standard for evaluating systems for the analysis of ST-T changes in ambulatory electrocardiography. (1992) (354)
Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. (2005) (323)
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. (2006) (263)
Hyperinsulinemia and Autonomic Nervous System Dysfunction in Obesity: Effects of Weight Loss (2001) (247)
Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. (2006) (205)
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure (1998) (199)
Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. (2001) (173)
Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. (2004) (168)
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. (2013) (164)
Long-term ST database: A reference for the development and evaluation of automated ischaemia detectors and for the study of the dynamics of myocardial ischaemia (2003) (155)
Autonomic and hemodynamic responses to insulin in lean and obese humans. (1998) (149)
Statin therapy in COVID-19 infection (2020) (146)
Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. (2007) (141)
The Circulating Levels of Cardiac Natriuretic Hormones in Healthy Adults: Effects of Age and Sex (2002) (136)
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis. (2017) (134)
Estimation of the power spectral density in nonstationary cardiovascular time series: assessing the role of the time-frequency representations (TFR) (1996) (132)
Myocardial Fibrosis as a Key Determinant of Left Ventricular Remodeling in Idiopathic Dilated Cardiomyopathy: A Contrast-Enhanced Cardiovascular Magnetic Study (2013) (127)
The paradox of low BNP levels in obesity (2011) (122)
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis (2018) (121)
Gamma-glutamyltransferase activity in human atherosclerotic plaques--biochemical similarities with the circulating enzyme. (2009) (120)
Treatment of cardiac transthyretin amyloidosis: an update. (2019) (110)
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T. (2018) (108)
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II (2010) (107)
Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. (2008) (104)
Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure (2004) (102)
Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. (2009) (102)
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I (2010) (102)
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis. (2019) (101)
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies (2020) (101)
C‐type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity (2005) (99)
The significance of serum γ-glutamyltransferase in cardiovascular diseases (2004) (97)
Heart involvement and systemic sclerosis (2005) (96)
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure. (2017) (94)
Old and new biomarkers of heart failure (2009) (93)
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. (1997) (89)
β-Lipoprotein- and LDL-associated serum γ-glutamyltransferase in patients with coronary atherosclerosis (2006) (87)
Incremental Prognostic Value of Myocardial Fibrosis in Patients With Non–Ischemic Cardiomyopathy Without Congestive Heart Failure (2014) (85)
Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. (1999) (85)
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natr (2004) (83)
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction. (2019) (83)
Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure. (2007) (82)
Improved exercise capacity with acute aminophylline administration in patients with syndrome X. (1989) (82)
Insulin prolongs the QTc interval in humans. (2000) (79)
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: a multicenter study in Italy. (2015) (77)
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice (2016) (77)
Markers of fibrosis, inflammation, and remodeling pathways in heart failure. (2015) (77)
Awake Blood Pressure Variability, Inflammatory Markers and Target Organ Damage in Newly Diagnosed Hypertension (2008) (76)
Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. (2015) (75)
Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP. (2005) (75)
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis (2004) (75)
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study. (2020) (74)
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long‐term comparison (2017) (74)
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week. (2019) (73)
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients. (2009) (72)
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. (2008) (71)
Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations (2008) (67)
Personality traits and heart rate variability predict long-term cardiac mortality after myocardial infarction. (2005) (67)
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction. (2019) (66)
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart (2008) (66)
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy. (2014) (65)
A system for the detection of ischemic episodes in ambulatory ECG (1995) (64)
Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP. (2009) (64)
The European ST-T database: development, distribution and use (1990) (63)
Early assessment of heart rate variability is predictive of in-hospital death and major complications after acute myocardial infarction. (2004) (63)
Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay (2006) (63)
A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis. (2008) (62)
Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction (2003) (61)
Serum gamma-glutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption. (2002) (60)
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead (2020) (60)
Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations. (2015) (59)
Additive prognostic value of gamma-glutamyltransferase in coronary artery disease. (2009) (59)
Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. (2006) (59)
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis (2019) (58)
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure (2013) (58)
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. (2011) (58)
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients (2000) (58)
Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay. (2007) (57)
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy (2015) (57)
Silent myocardial damage in cocaine addicts (2011) (57)
Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. (2009) (56)
Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: A systematic review and meta‐analysis (2019) (55)
Prognostic value of plasma renin activity in heart failure. (2011) (55)
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy. (2015) (54)
Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. (2006) (54)
[Recommendations for the clinical use of cardiac natriuretic peptides]. (2005) (53)
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week. (2020) (51)
Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. (2012) (51)
Hyperthyroidism is associated with lengthening of ventricular repolarization (2001) (49)
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging (2015) (48)
Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots. (2018) (48)
Neuro‐hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure (2006) (48)
Accuracy of b‐GGT fraction for the diagnosis of non‐alcoholic fatty liver disease (2012) (47)
Spectral analysis of cardiovascular time series by the S-transform (1997) (46)
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure. (2017) (45)
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction (2019) (45)
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction. (2019) (45)
The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis. (2009) (45)
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years (2019) (45)
Gamma-glutamyltransferase as a cardiovascular risk factor. (2006) (44)
Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients. (2012) (44)
Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology. (2008) (44)
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings (2020) (43)
Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide. (2005) (43)
Real-time dynamic carbon dioxide administration: a novel treatment strategy for stabilization of periodic breathing with potential application to central sleep apnea. (2010) (42)
Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone. (2007) (41)
Assessment of heart involvement. (2003) (41)
Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone (2019) (40)
Abnormal T2-STIR Magnetic Resonance in Hypertrophic Cardiomyopathy: A Marker of Advanced Disease and Electrical Myocardial Instability (2014) (40)
Cardiac production of C-type natriuretic peptide in heart failure (2006) (40)
Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients (2011) (40)
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? (2018) (39)
Biomarkers for the diagnosis and management of heart failure (2021) (39)
Influence of Gender on Circulating Cardiac Natriuretic Hormones in Patients with Heart Failure (2003) (38)
Treatment of end-stage congestive heart failure by extracorporeal ultrafiltration. (1987) (38)
CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. (2013) (38)
Pirfenidone is a Cardioprotective Drug: Mechanisms of Action and Preclinical Evidence. (2020) (38)
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy. (2016) (38)
Sex-related differences in chronic heart failure. (2018) (38)
Omics phenotyping in heart failure: the next frontier. (2020) (37)
Energy metabolism in the normal and in the diabetic heart. (2009) (37)
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions. (2020) (37)
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. (2003) (36)
Gamma-Glutamyltransferase Fractions in Human Plasma and Bile: Characteristic and Biogenesis (2014) (35)
Reference values for urinary neutrophil gelatinase-associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform (2013) (35)
Cardiovascular risk factors and γ-glutamyltransferase fractions in healthy individuals (2010) (34)
Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin I (2018) (34)
Fractions of plasma gamma-glutamyltransferase in healthy individuals: reference values. (2008) (33)
Adaptive filtering of ECG signal for deriving respiratory activity (1990) (33)
C-type natriuretic peptide and heart failure. (2006) (33)
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy. (2004) (32)
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. (2013) (31)
Human head exposure to a 37 Hz electromagnetic field: Effects on blood pressure, somatosensory perception, and related parameters (2004) (31)
Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction (2007) (30)
RNA-targeting and gene editing therapies for transthyretin amyloidosis (2022) (30)
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis (2020) (30)
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences. (2015) (30)
Cardiac troponins as biomarkers for cardiac disease. (2019) (29)
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea. (2016) (29)
Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure (2009) (29)
Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease. (2013) (29)
Heart failure and anemia: Effects on prognostic variables. (2017) (29)
C-type natriuretic peptide and its relation to non-invasive indices of left ventricular function in patients with chronic heart failure (2008) (29)
Therapies for cardiac light chain amyloidosis: An update. (2018) (29)
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation (2020) (29)
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. (2016) (29)
Clinical relevance of non-cardiac determinants of natriuretic peptide levels (2008) (29)
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation (2005) (28)
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure. (2017) (28)
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation (2015) (28)
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome (2019) (28)
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score. (2019) (27)
Amino-Terminal Fragment of Pro-Brain Natriuretic Hormone Identifies Functional Impairment and Right Ventricular Overload in Operated Tetralogy of Fallot Patients (2007) (27)
Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure. (2009) (27)
Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy (2019) (27)
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method (2004) (27)
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction. (2015) (27)
Cultured human cells release soluble γ-glutamyltransferase complexes corresponding to the plasma b-GGT (2009) (26)
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? (2015) (26)
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy. (2018) (26)
Low triiodothyronine and exercise capacity in heart failure. (2012) (26)
Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database (2017) (26)
Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis. (2020) (26)
Fuzzy modelling of the expert's knowledge in ECG-based ischaemia detection (1996) (26)
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance (2020) (25)
Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. (2005) (25)
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training (2008) (25)
Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis (2018) (25)
Development of an electronic medical record for patient care in cardiology (1997) (24)
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. (2019) (24)
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. (2013) (24)
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. (2014) (24)
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (2022) (24)
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis (2014) (24)
The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study. (2019) (23)
Cardiovascular disease and COVID-19: les liaisons dangereuses (2020) (23)
Upright Cheyne-Stokes Respiration in Patients With Heart Failure. (2020) (23)
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure. (2018) (22)
Role of right ventricular involvement in acute myocarditis, assessed by cardiac magnetic resonance. (2018) (22)
Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study (2018) (22)
Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure. (2007) (22)
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure. (2019) (21)
Contribution of the Lung to the Genesis of Cheyne‐Stokes Respiration in Heart Failure: Plant Gain Beyond Chemoreflex Gain and Circulation Time (2019) (21)
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review. (2022) (21)
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). (2015) (21)
S38G single-nucleotide polymorphism at the KCNE1 locus is associated with heart failure. (2010) (21)
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease (2017) (21)
Prognostic Role of Cardiac Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy. (2018) (20)
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T (2020) (20)
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure. (2016) (20)
Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide? (2011) (20)
Protecting higher education institutions from COVID-19: insights from an Italian experience (2020) (20)
Use of biomarkers to diagnose and manage cardiac amyloidosis (2021) (19)
Cardiogenic shock and acute kidney injury: the rule rather than the exception (2020) (19)
Clinical relevance of biological variation of B-type natriuretic peptide. (2005) (19)
High-sensitivity γ-glutamyltransferase fraction pattern in alcohol addicts and abstainers. (2013) (19)
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction (2018) (19)
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy. (2016) (19)
The Long-Term ST database: a research resource for algorithm development and physiologic studies of transient myocardial ischemia (2000) (18)
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias. (2016) (18)
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets (2020) (18)
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction (2020) (18)
Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial Endocarditis (2012) (18)
When the heart is burning: amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease. (2011) (17)
Amiodarone as a possible therapy for coronavirus infection (2020) (17)
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa (2007) (17)
Benefit of buspirone on chemoreflex and central apnoeas in heart failure: a randomized controlled crossover trial (2020) (17)
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives (2016) (17)
Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction (2019) (16)
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group. (2015) (16)
Prognostic Impact of QRS Axis Deviation in Patients Treated With Cardiac Resynchronization Therapy (2016) (16)
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches. (2016) (16)
Ultrafiltration: a rational treatment for heart failure. (1989) (16)
A multiresolution transform for the analysis of cardiovascular time series (1998) (16)
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group. (2019) (16)
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study. (2021) (16)
Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis. (2021) (16)
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies (2022) (16)
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study. (2020) (16)
A spectral approach for heart rate fluctuations analysis (1988) (16)
Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology (2021) (16)
Implantable cardioverter-defibrillator-computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study. (2017) (15)
Postmortem cardiac magnetic resonance in sudden cardiac death (2018) (15)
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis. (2020) (15)
A simple echocardiographic score to rule out cardiac amyloidosis (2020) (15)
Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis (2020) (15)
Use of an electronic medical record in a department of cardiology (2000) (15)
Predictability and nonlinearity of the heart rhythm (1998) (15)
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure. (2019) (15)
NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories. (2021) (15)
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? (2015) (15)
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis (2015) (15)
Safety and Efficacy of Amiodarone in a Patient With COVID-19 (2020) (15)
Fibrosis and mortality in patients with dilated cardiomyopathy. (2013) (14)
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction. (2020) (14)
Natriuretic peptides : the hormones of the heart (2006) (14)
Analysis of generic coupling between EEG activity and PETCO2 in free breathing and breath-hold tasks using Maximal Information Coefficient (MIC) (2018) (14)
When gonads talk to the heart sex hormones and cardiac endocrine function. (2011) (14)
ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure (2017) (14)
Endocrine paradox in heart failure: resistance to biological effects of cardiac natriuretic hormones. (2004) (14)
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure (2018) (14)
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey (2021) (14)
Effect of low‐dose colchicine in acute and chronic coronary syndromes: A systematic review and meta‐analysis (2020) (14)
Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake (2018) (14)
Periodic Breathing during Incremental Exercise (2017) (14)
Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange. (2000) (14)
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure. (2013) (14)
Serum gamma‐glutamyl transpeptidase: A prognostic marker in cardiovascular diseases (2003) (14)
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples (2019) (14)
Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis (2004) (14)
Vericiguat for Heart Failure with Reduced Ejection Fraction (2021) (14)
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction (2019) (14)
Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNA gene duplication (2010) (13)
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform (2015) (13)
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease (2021) (13)
New and emerging biomarkers of heart failure (2009) (13)
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance (2021) (13)
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (13)
Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure. (2010) (13)
A long-term ST database for development and evaluation of ischemia detectors (1998) (13)
Amiodarone as a possible therapy for coronavirus infection. (2020) (13)
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier (2009) (13)
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation (2017) (13)
Cardiac biomarkers and risk assessment in patients undergoing major non-cardiac surgery: time to revise the guidelines? (2014) (13)
Pirfenidone as a novel cardiac protective treatment (2021) (13)
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism (2015) (12)
Analytical and clinical performance of an automated chemiluminescent immunoassay for direct renin measurement : comparison with PRA and aldosterone assays (2005) (12)
Development of a long term database for assessing the performance of transient ischemia detectors (1996) (12)
Prognostic value of alveolar volume in systolic heart failure: a prospective observational study (2013) (12)
PET-CT evaluation of amyloid systemic involvement with [18F]-florbetaben in patient with proved cardiac amyloidosis: a case report (2017) (12)
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation. (2018) (12)
Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study (2020) (12)
Cardiac Magnetic Resonance Evaluation of Pulmonary Transit Time and Blood Volume in Adult Congenital Heart disease (2019) (12)
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias (2018) (11)
Concordant versus discordant left bundle branch block in heart failure patients: novel clinical value of an old electrocardiographic diagnosis. (2010) (11)
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: a cardiac MR study. (2013) (11)
Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction. (2021) (11)
Application of the Seattle Heart Failure Model in Patients on Cardiac Resynchronization Therapy (2012) (11)
Current and emerging drug targets in heart failure treatment (2021) (11)
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function (2019) (11)
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis (2020) (11)
Can hypnosis modify the sympathetic-parasympathetic balance at heart level? (1992) (11)
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology (2022) (11)
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis. (2022) (11)
High sensitivity troponin might be a marker of subclinical scleroderma heart involvement: a preliminary study (2017) (11)
Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation. (2010) (11)
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. (2008) (11)
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data. (2020) (11)
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy. (2020) (11)
Thromboembolism and bleeding in systemic amyloidosis: a review (2021) (10)
Sleep Disordered Breathing and Arrhythmia Burden in Pacemaker Recipients (2010) (10)
Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction. (2017) (10)
Medical record system for cardiology and cardiac surgery (1999) (10)
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity. (2021) (10)
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data (2021) (10)
The Barthel Index in elderly acute heart failure patients. Frailty matters. (2018) (10)
Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (10)
Markers of arrhythmogenic risk in hypertensive subjects. (2011) (10)
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure. (2015) (10)
Mineralocorticoid receptor antagonists for heart failure: a real‐life observational study (2018) (10)
gamma-glutamyltransferase and pathogenesis of cardiovascular diseases. (2007) (10)
RESP-24: a computer program for the investigation of 24-h breathing abnormalities in heart failure patients (2002) (10)
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction (2020) (9)
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. (2016) (9)
Platelet activation, gamma-glutamyltransferase and stent restenosis: comment on the article by Ulus et al. (2007) (9)
Molecular Autopsy of Sudden Cardiac Death in the Genomics Era (2021) (9)
Deep-learning-based cardiac amyloidosis classification from early acquired pet images (2021) (9)
Design and optimization of lipid-modified poly(amidoamine) dendrimer coated iron oxide nanoparticles as probes for biomedical applications. (2015) (9)
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure (2019) (9)
Management of complications of cardiac amyloidosis: 10 questions and answers. (2020) (9)
Left ventricular ejection fraction for risk stratification in chronic systolic heart failure. (2018) (9)
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction. (2021) (9)
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery (2018) (8)
Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure. (2019) (8)
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure. (2022) (8)
Plasma adrenomedullin relation with doppler‐derived dP/dt in patients with congestive heart failure (2006) (8)
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system (2006) (8)
Electrocardiographic and signal monitoring in ischaemic heart disease: state of the art and perspective. (1997) (8)
Central Apnoeas and Ticagrelor Related Dyspnoea in Patients with Acute Coronary Syndrome. (2020) (8)
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users. (2014) (8)
Independent of Alcohol Consumption Serum Gamma-Glutamyltransferase as a Risk Factor of Ischemic Stroke Might (2002) (8)
The value of hospital personnel serological screening in an integrated COVID-19 infection prevention and control strategy (2020) (8)
Evaluation of analytical performance of Advia® TnI ultra immunoassay and comparison with Access® AccuTnI™ method (2008) (8)
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis (2021) (8)
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure (2019) (8)
Sleep-Disordered Breathing and Nocturnal Hypoxemia in Precapillary Pulmonary Hypertension: Prevalence, Pathophysiological Determinants, and Clinical Consequences (2021) (8)
B-type natriuretic peptide secretion following scuba diving. (2011) (8)
Colchicine for the Treatment of Coronary Artery Disease. (2020) (8)
Sequential Estimation Of The Power Spectrum For The Analysis Of Variability Of Non Stationary Cardiovascular Signals (1991) (8)
Troponins in cardiac amyloidosis: multipurpose markers (2014) (8)
Circulating gamma‐glutamyltransferase fractions in cirrhosis (2014) (8)
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension. (2020) (8)
Adaptive modelling of biological time series for artifact detection (1993) (8)
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease. (2010) (7)
Echocardiographic assessment of pediatric semilunar valve disease (2017) (7)
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction. (2016) (7)
An informative system for structured data management to build a cardiological multidimensional database (2002) (7)
Analysis of non-stationary heart rate series by evolutionary periodogram (1995) (7)
Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin (2012) (7)
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy (2016) (7)
Analysis of variability: a system for comparing classical, parametric, adaptive and Wigner-Ville power spectral estimators (1990) (7)
The Potential Roles of Gamma-Glutamyltransferase Activity in the Progression of Atherosclerosis and Cardiovascular Diseases (2006) (7)
Sex-related differences in ventricular remodeling after myocardial infarction. (2021) (7)
Characterization of the cardiovascular autonomic influence through time frequency spectrum analysis (1992) (7)
The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) (2018) (7)
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure. (2018) (7)
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid‐range ejection fraction (2021) (7)
Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates (2020) (7)
A Cross-Correlational Analysis between Electroencephalographic and End-Tidal Carbon Dioxide Signals: Methodological Issues in the Presence of Missing Data and Real Data Results (2016) (7)
Cardiac sympathetic denervation in wild-type transthyretin amyloidosis (2020) (7)
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis (2022) (7)
Abnormal hyperventilation in patients with hepatic cirrhosis: role of enhanced chemosensitivity to carbon dioxide. (2012) (7)
Clinical characteristics of anginal pain in man. (1989) (7)
The CARPEDIEM Algorithm: A Rule-Based System for Identifying Heart Failure Phenotype with a Precision Public Health Approach (2018) (7)
Recurrence quantification Analysis describes the complex and deterministic behaviour of heart rate variability in healthy subjects. IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE (1998) (7)
Cardiac angiotensin receptor expression in hypothyroidism: back to fetal gene programme? (2008) (7)
Forced expiratory volume in one second: prognostic value in systolic heart failure. (2013) (7)
γ-glutamyltransferase and pathogenesis of cardiovascular diseases (2007) (6)
Hypnosis effect on RR interval and blood pressure variability. (1996) (6)
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease (2017) (6)
Magnetic Resonance Imaging Correlates of Left Bundle Branch Disease in Patients With Nonischemic Cardiomyopathy. (2018) (6)
Restrictive cardiomyopathy: definition and diagnosis (2022) (6)
Prediction of the Chemoreflex Gain by Common Clinical Variables in Heart Failure (2016) (6)
Heart Rate Variability and Myocardial Infarction: Acute and Subacute Phase (1996) (6)
Linear and Nonlinear Properties of Heart Rate Variability: Influence of Obesity (1999) (6)
The bottleneck of cardiac rehabilitation for patients with coronary artery disease: How to overcome (2018) (6)
Value of the HFA‐PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis (2022) (6)
Self-Inserted Needles in the Heart. (2015) (6)
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction. (2021) (6)
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register (2021) (6)
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction (2021) (6)
The paradox of low B‐type natriuretic peptide levels in obesity revisited: does sex matter? (2018) (6)
Automatic analysis of EEG pattern during sleep in Cheyne-Stokes respiration in heart failure. (2011) (6)
Monitoring patient status through principal components analysis (1991) (6)
Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines (2022) (6)
The contribution of ventricular tachyarrhythmias to the genesis of cardiac pain during transient myocardial ischaemia in patients with variant angina. (1988) (6)
Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation (2020) (5)
Cardiac magnetic resonance in patients with muscular dystrophies. (2020) (5)
sST2 for Outcome Prediction in Acute Heart Failure: Which Is the Best Cutoff? (2019) (5)
Highly Elevated Plasma γ‐Glutamyltransferase Elevations: A Trait Caused by γ‐Glutamyltransferase 1 Transmembrane Mutations (2019) (5)
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond (2022) (5)
Imaging predictors of incident heart failure: a systematic review and meta-analysis. (2020) (5)
Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure (2022) (5)
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis. (2020) (5)
[Sacubitril/valsartan, a new and effective treatment for heart failure with reduced ejection fraction]. (2017) (5)
Cardiac amyloidosis: The starched heart (2018) (5)
Developmental variations of plasma gamma-glutamyltransferase fractions in humans and in laboratory mammalians (2012) (5)
Arterial hypertension and atrial fibrillation: standard and advanced echocardiography from diagnosis to prognostication (2017) (5)
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin (2022) (5)
Sunday, 26 August 2012 (2012) (5)
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? (2022) (5)
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis (2015) (5)
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise (2015) (5)
Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure (2022) (5)
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images (2021) (5)
Findings from long-term electrocardiographic monitoring of patients with variant angina in a coronary care unit. (1987) (5)
Detection of Nonlinearity in the Healthy Heart Rhythm (1997) (5)
Improvement of Walking Distance in Patients with Intermittent Claudication by Chronic Local Therapy with Isosorbide Dinitrate Ointment (1988) (5)
[Autonomic nervous system in diabetes]. (2001) (5)
No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril. (2019) (5)
Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences (2021) (5)
Correction of procedural arterial pseudoaneurysms: established and novel procedures (2014) (4)
The triglyceride/HDL cholesterol ratio and TyG index predict coronary atherosclerosis and outcome in the general population. (2021) (4)
Building medical knowledge from real world registries: The case of heart failure (2018) (4)
[Recent knowledges on chemosensitivity to hypoxia and hypercapnia in cardiovascular disease]. (2010) (4)
Medication Reconciliation During Hospitalization and in Hospital-Home Interface: An Observational Retrospective Study (2017) (4)
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS) (2022) (4)
Compact representation of autonomic stimulation on cardiorespiratory signals by principal component analysis (1993) (4)
Re : Safety of Intraventricular Sodium Nitroprusside and Thiosulfate for the Treatment of Cerebral Vasospasm in the Intensive Care Unit Setting (2002) (4)
Polymorphisms in the eNOS gene and the risk of coronary artery disease: Making the case for genome-wide association studies (2018) (4)
Remote biosignal monitoring, display, online analysis and retrieval (2001) (4)
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients]. (2016) (4)
Statins during daptomycin therapy: to give or not to give? (2019) (4)
Research protocol for the validation of a new portable technology for real-time continuous monitoring of Early Warning Score (EWS) in hospital practice and for an early-stage multistakeholder assessment (2020) (4)
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications (2022) (4)
Subclinical cardiac damage in cancer patients before chemotherapy (2021) (4)
Serum γ-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis? (2009) (4)
Post-mortem CMR in a model of sudden death due to myocardial ischemia: validation with connexin-43 (2021) (4)
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences (2021) (4)
Quality of life and outcome in heart failure with preserved ejection fraction: When sex matters. (2018) (4)
A Contrast-Enhanced Cardiovascular Magnetic Study Myocardial Fibrosis as a Key Determinant of Left Ventricular Remodeling in Idiopathic (2013) (4)
Treating chemoreflex in heart failure: modulation or demolition? (2014) (4)
OLD AND NEW EQUATIONS FOR MAXIMAL HEART RATE PREDICTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION ON BETA-BLOCKERS TREATMENT. RESULTS FROM THE MECKI SCORE DATASET. (2022) (4)
Targeting periodic breathing in heart failure patients, and treating it-gently. (2014) (4)
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy (2022) (4)
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction (2015) (4)
To Breathe, or Not to Breathe: That Is the Question (2017) (4)
The Breathless Heart (2017) (4)
Cardiac light-chain deposition disease relapsing in the transplanted heart (2017) (4)
Complexity of heart rate, blood pressure and respiration disclosed by pattern fractal analysis (2000) (4)
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: results from a large-scale screening program based on rapid serological testing. (2020) (4)
CARDIOVASCULAR DEATH RISK IN RECOVERED MID-RANGE EJECTION FRACTION HEART FAILURE: INSIGHTS FROM CARDIOPULMONARY EXERCISE TEST. (2020) (4)
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance. (2014) (4)
Documento di consenso ANMCO/ELAS/SIBioC: Raccomandazioni sull'impiego dei biomarcatori cardiaci nello scompenso cardiaco (2016) (4)
Resistant hypertension: an overview. (2017) (4)
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond (2022) (3)
An open system for managing long-term ECG recordings (2000) (3)
The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe (2021) (3)
Management of complications of cardiac amyloidosis: 10 questions and answers. (2021) (3)
Long-term monitoring of sleep apnea at home in heart failure patients: preliminary results from the HHH study (2004) (3)
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study". (2013) (3)
Multichannel spectral analysis of R-R and respiratory series from 24-hour Holter recordings (1994) (3)
Heart rate variability modified by altitude exposure (2000) (3)
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern (2022) (3)
A dialogue between the editor-in-chief and a deputy editor of a cardiology journal during the coronavirus outbreak: Take-home messages from the Italian experience (2020) (3)
MYOCARDIAL GADOLINIUM KINETICS EVALUATION AT MRI FOR THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS (2013) (3)
Non linear filtering for the estimation of the respiratory component in heart rate (1994) (3)
Validity of transit time–based blood pressure measurements in patients with and without heart failure or pulmonary arterial hypertension across different breathing maneuvers (2019) (3)
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration (2020) (3)
P292 REDEFINING THE EPIDEMIOLOGY OF CARDIAC AMYLOIDOSIS. A SYSTEMATIC REVIEW OF SCREENING STUDIES (2022) (3)
N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T hold diagnostic value in cardiac amyloidosis (2023) (3)
Abolished Vagal Tone Associated with Thyrotoxicosis Triggers Prinzmetal Variant Angina and Paroxysmal Atrial Fibrillation (2000) (3)
How to take arms against central apneas in heart failure (2017) (3)
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure (2021) (3)
BUSPIRONE IS EFFECTIVE ON CENTRAL APNEAS IN PATIENTS WITH SYSTOLIC HEART FAILURE (2018) (3)
Recurrence quantification analysis describes the complex and deterministic behavior of heart rate variability in healthy subjects (1998) (3)
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides. (2015) (3)
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis (2021) (3)
Biomarkers for growth prediction of abdominal aortic aneurysm: A step forward(?) (2019) (3)
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis (2020) (3)
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis (2022) (3)
The unbearable underreporting of comorbidities in heart failure clinical trials (2020) (3)
Microvascular responses to aldosterone in hamster cheek pouch microcirculation. (2013) (3)
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? (2015) (3)
Effectiveness of adaptive filtering in cancelling the respiratory component from cardiovascular series (1996) (3)
An informative system for chronic heart failure patients follow-up (CHeF) (2001) (3)
Atrial amyloidosis: mechanisms and clinical manifestations (2022) (3)
Cardiac magnetic resonance in patients with muscular dystrophies. (2020) (3)
Heart rate variability and myocardial infarction: acute and subacute phase. CNR-PF FATMA Multicenter Study on psycho-neurological risk factors in acute myocardial infarction. (1996) (3)
Breathless heart: only when the neck is deep in water? (2013) (3)
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia. (2016) (3)
Surgery casualties: do not leave hearts behind enemy lines. (2014) (3)
Restrictive spirometry pattern and abnormal cardiopulmonary response to exercise in transthyretin cardiac amyloidosis (2022) (3)
Monday, 27 August 2012 (2012) (3)
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block (2021) (3)
ABACUS: a knowledge-based system for the interpretation of arrhythmias in long term ECG (1993) (3)
Raccomandazioni sull'Impiego Clinico dei Peptidi Natriuretici Cardiaci: Linee Guida (2005) (3)
Targeting social disadvantage to prevent early development of heart failure. (2019) (2)
·AN APPROACH TO CARDIORESPIRATOTY ACTIVITY MONITORING THROUGH PRINCIPAL COMPONENT ANALYSIS. J. AMB. MONITOR., 5:167-174, 1992 (1992) (2)
Overlapping effects of miR-21 inhibition and drugs for idiopathic pulmonary fibrosis: rationale for repurposing nintedanib as a novel treatment for ischemia/reperfusion injury. (2020) (2)
Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure (2021) (2)
Association between implantable defibrillator‐detected sleep apnea and atrial fibrillation: The DASAP‐HF study (2022) (2)
Etiology, clinical presentation, and management of left main coronary artery aneurysms (2022) (2)
Electrocardiographic monitoring: temporal versus spatial information and data processing. (1986) (2)
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? (2018) (2)
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure (2020) (2)
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers. (2022) (2)
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? (2020) (2)
Prognostic value of implantable defibrillator-computed respiratory disturbance index: The DASAP-HF study. (2020) (2)
The ST2-SCD score and the conundrum of sudden death prediction in heart failure. (2019) (2)
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis (2020) (2)
A methodology for evaluating the influence of the respiratory component in measuring the complexity of heart rate variability (1992) (2)
P3525Buspirone effect on chemoreflex and central apneas in heart failure (2019) (2)
18-FDG PET for large vessel vasculitis diagnosis and follow-up. (2020) (2)
Serum Gamma-Glutamyltransferase and Intima-Media Thickness: Pointing Again to Wall/Lumen Interactions in Atherosclerosis (2011) (2)
GALECTIN-3 AND MYOCARDIAL FIBROSIS AT CARDIAC MAGNETIC RESONANCE IN NONISCHEMIC DILATED CARDIOMYOPATHY (2014) (2)
Comparison between the diagnostic accuracy of BNP and NT-proBNP immunoassays in chronic and acute heart failure: a systematic review (2006) (2)
[Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients]. (2010) (2)
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology (2022) (2)
71 Improved early diagnosis of heart failure with B-type natriuretic peptides: comparison between BNP and NT-proBNP diagnostic accuracy (2007) (2)
“Inconclusive” Remarks: Past, Present and Future of Natriuretic Peptides (2006) (2)
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease. (2017) (2)
The Incremental Prognostic Value of Myocardial Fibrosis in Patients With Non-Ischemic Cardiomyopathy Without Congestive Heart Failure Masci et al: Fibrosis in NICM Patients Without CHF (2017) (2)
A workstation for data consultation and clinical decision-support in the department of cardiology (1994) (2)
Clinical Considerations and Applications in Cardiac Diseases (2006) (2)
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism (2022) (2)
Circadian dynamics of respiratory parameters from ambulatory monitoring (1994) (2)
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis. (2022) (2)
A new cardiovascular signal database for assessing methods for analysis of ischemic heart disease (1996) (2)
Clinical Applications in Extra-Cardiac Diseases (2006) (2)
Historical Background and Glossary of the Apnea Phenomenon (2017) (2)
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers (2022) (2)
Myocardial salvage is increased after sympathetic renal denervation in a pig model of acute infarction (2020) (2)
Speckle tracking echocardiography in heart failure development and progression in patients with apneas (2021) (2)
Multimodality Imaging - MRI - CT and Nuclear Cardiology: Magnetic Resonance Imaging (2012) (2)
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? (2022) (2)
Cardiac Natriuretic Hormone System as Target for Cardiovascular Therapy (2006) (2)
P4542Revisiting the obesity paradox in heart failure: percent body fat as predictor of biomarkers and outcome (2019) (2)
Longer sleep duration and poor sleep quality as risk factors for hyperlipidaemia (2019) (2)
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update (2022) (2)
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension (2020) (2)
A review from the Biomarkers Working Group of the Heart Failure Association of the ESC: A review from the Biomarkers Working Group of the Heart Failure Association of the ESC. (2022) (2)
Pick your threshold: a comparison among different methods of anaerobic threshold evaluation in heart failure prognostic assessment. (2022) (2)
Detection of apneas during 24-Hour ambulatory monitoring of ECG and respiration in chronic heart failure patients with Cheyne-Stokes breathing (1999) (2)
Rituximab as a novel treatment for heart failure: evidence from a case series (2019) (2)
The authors of the article cited above respond (2007) (2)
Low-Thrombogenicity Mechanical Heart Valves: Which Antithrombotic Strategy? (2018) (2)
Creatine deficiency and heart failure (2021) (2)
Natriuretic peptide testing in primary care patients (2008) (2)
A two-channel adaptive filtering approach for recognition of the QRS morphology (1991) (2)
The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations (2021) (1)
α-1 Antitrypsin as a potential biomarker in chronic heart failure. (2020) (1)
Targeting and Treating Apneas (2017) (1)
Treatment Options in AF Patients with Cancer; Focus on Catheter Ablation (2022) (1)
Il dosaggio delle troponine cardiache con metodi ad alta sensibilità: caratteristiche analitiche e rilevanza clinica (2009) (1)
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase (2002) (1)
Assessing Cardiac Response to Patisiran by Changes in Extracellular Volume: Potential Issues. (2021) (1)
The search for efficient diagnostic and prognostic biomarkers of heart failure. (2016) (1)
Tafamidis is entering the clinical arena for the treatment of transthyretin‐related cardiomyopathy: certainties and unmet needs (2021) (1)
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis (2023) (1)
A global polar diagram of the zeroes of the characteristic function of an autoregressive process to describe the EEG sleep pattern (1987) (1)
Searching for Diagnostic Biomarkers of HFpEF: Methodological Issues. (2020) (1)
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? (2017) (1)
[Biomarkers in heart failure: an update]. (2013) (1)
Diagnostic Tools: The Easier, the Better (2017) (1)
Endothelium-dependent and independent vasodilation is impaired at peripheral microcirculatory level in patients with coronary artery disease (2000) (1)
Renin profiling predicts neurohormonal response to sacubitril/valsartan (2020) (1)
The revolution of ATTR amyloidosis in cardiology: certainties, gray zones and perspectives. (2022) (1)
P3161Pitfalls in end-of-life care of heart failure patients: evidence from a regional italian database (2018) (1)
Bivariate spectral analysis of nonstationary cardiovascular variability series through cross Wigner distribution (1996) (1)
41 Circulating levels and prognostic cut-offs of sST2, high-sensitivity troponin T, and NT-proBNP in women vs. men with chronic heart failure (2021) (1)
Daptomycin-based aminoglycoside-sparing therapy for streptococcal endocarditis: a retrospective multicenter study (2020) (1)
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset. (2021) (1)
611 N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of early/mild forms of heart failure (2005) (1)
High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis (2020) (1)
Cardiac biomarkers retain prognostic significance in patients with heart failure and chronic obstructive pulmonary disease. (2021) (1)
Scoring frailty in patients hospitalized for heart failure: Impact on prognosis (and decision making, too?). (2020) (1)
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic Registry (2021) (1)
40 Exertional periodic breathing is frequent in heart failure patients: clinical and neuro‐hormonal correlates (2008) (1)
Evaluating biomarkers as predictors of cancer therapy cardiotoxicity: all you need is a meta-analysis? Reply. (2020) (1)
Prognostic value of sST2 in heart failure patients with diabetes (2021) (1)
Author response for "Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta‐Analysis" (2019) (1)
Clinical Evidence of Myocardial Damage in Patients with Acute Subarachnoid Hemorrhage (1992) (1)
Amino terminal fragment of pro-B-type natriuretic peptide for complex congenital heart diseases: one for all, all for one? (2014) (1)
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control (2019) (1)
What Is Hidden Behind Inferior Negative T Waves (2019) (1)
Unravelling the role of sex in the pathophysiology, phenotypic expression and diagnosis of cardiac amyloidosis (2022) (1)
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient (2021) (1)
Adaptive filtering method for the hemodynamic evaluation of the ventricular assist device (1989) (1)
Beta-blockers: A real antidote for cocaine-related heart disease? (2019) (1)
Artefact rejection from Wigner Ville spectra of cardiovascular series in autonomic tests (1993) (1)
Validation of a novel algorithm for ventricular repolarization analysis: use of Physionet resources (2003) (1)
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry. (2017) (1)
NT-proBNP and High-Sensitivity Troponin T Hold Diagnostic Value in Cardiac Amyloidosis. (2022) (1)
Can we measure how hot the plaque is? Not yet, but... (2013) (1)
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation (2022) (1)
Transient myocardial ischemia and cardiac pain. Importance of duration of ischemia, heart rate behaviour and circadian distribution. (1989) (1)
Apnea detection from 24-hour recordings of respiration in chronic heart failure patients (2000) (1)
Periodic breathing influence on heart rate variability (1996) (1)
703 Heart rate variability and personality traits in acute myocardial infarction (1998) (1)
Detection of spontaneous episodes in post-infarction angina. Comparison between CCU and Holter monitoring. (1986) (1)
Central apneas, chemoreflex sensitivity, and buspirone in spinal cord injury: a word of caution. (2021) (1)
Non-transmural myocardial infarction associated with regional contractile function is an independent predictor of positive outcome: an integrated approach to myocardial viability (2021) (1)
B-type natriuretic peptides are a marker for congenital heart disease in neonates: cheap, feasible, and accurate; why not use them for screening?. (2013) (1)
PHARMACOLOGICAL INHIBITION OF GALECTIN-3 AND ALDOSTERONE PATHWAYS PREVENTS ISOPROTERENOL-INDUCED LEFT VENTRICULAR DYSFUNCTION AND FIBROSIS IN MICE (2015) (1)
Gamma-glutamyltransferase levels as a predictor of mortality in patients with ST-elevation myocardial infarction (2013) (1)
Underprescription of disease-modifying drugs in chronic heart failure: More is better? (2018) (1)
Tuesday, 28 August 2012 (2012) (1)
γ‐Glutamyltransferase activity in human atherosclerotic plaques: origin, prooxidant effects and potential roles in progression of disease (2007) (1)
ECHOCARDIOGRAPHIC BIVENTRICULAR COUPLING INDEX TO PREDICT PRE-CAPILLARY PULMONARY HYPERTENSION (2021) (1)
P2729NT-proBNP and high-sensitivity cardiac troponin T to diagnose cardiac amyloidosis (2019) (1)
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction (2021) (1)
Echocardiographic Biventricular Coupling Index to Predict Pre-Capillary Pulmonary Hypertension. (2022) (1)
Safety and efficacy of levosimendan in patients with cardiac amyloidosis. (2020) (1)
Exploratory analysis of nonlinear coupling between EEG global field power and end-tidal carbon dioxide in free breathing and breath-hold tasks (2016) (1)
PERSISTENCE OF PERIODIC BREATHING/CHEYNE-STOKES RESPIRATION AFTER TILT TABLE TEST DURING SHORT TERM RESPIRATORY MONITORING IN PATIENTS WITH SYSTOLIC HEART FAILURE (2018) (1)
Thyroid, Heart Failure, and Neuroendocrine Activation (2020) (1)
322Late gadolinium enhancement predicts appropriate defibrillator interventions in nonischaemic dilated cardiomyopathy (2019) (1)
Heart, kidney and FGF23: Les liaisons dangereuses. (2018) (1)
703 Ambulatory use of a cardio-respiratory wearable device for detection of Cheyne-Stokes respiration in heart failure (2003) (1)
パターンフラクタル解析によって明らかになった心拍数,血圧,および呼吸の複雑性 (2000) (1)
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart. (2018) (1)
Heart rate response to exercise and prognosis: Does rhythm matter? (2018) (1)
'… And now what to do?' Direct surgical trans-atrial endocardial pacing electrode implantation in a very complex situation. (2016) (1)
70 Deep learning to diagnose cardiac amyloidosis from cardiac magnetic resonance findings (2020) (1)
Scared to Death (2020) (1)
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease (2017) (1)
Combined bull's eye display of rest, stress and viability imaging in coronary artery disease (1995) (1)
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy (2018) (1)
I027: Circulating levels of cardiac natriuretic peptides measured by highly sensitive and specific IRMA methods in normal subjects and in patients with heart failure (1998) (1)
Intracoronary Delivery of Mitochondria to Prevent Ischemia–Reperfusion Injury (2020) (1)
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis (2021) (1)
Global warming, renal function and heart failure over 20 years. (2022) (1)
Linear and/or nonlinear behavior of heart rate? A comparative study using Lyapunov exponents, fractal dimension, conditional entropy and spectral analysis (2003) (1)
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases. (2023) (1)
Imaging-documented cardiovascular signal database for assessing methods for ischaemia analysis. (1997) (1)
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base. (2022) (1)
GAMMA-GLUTAMYLTRANSFERASE DEPOSITS IN HUMAN ATHEROSCLEROTIC PLAQUES: POTENTIAL RELATIONSHIPS WITH THE CIRCULATING ENZYME (2008) (1)
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes (1)
Urinary NGAL in acute heart failure revisited: the game is not over yet. (2022) (1)
B-type natriuretic peptide assay for complex congenital heart diseases: clinical relevance versus methodological issues. (2013) (1)
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing (2022) (1)
Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure. (2021) (1)
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardio-Ormocheck. (2011) (0)
Clinical and prognostic significance of left ventricular outflow tract velocity time integral (LVOT-VTI) in patients with chronic heart failure (2022) (0)
P286 ECHOCARDIOGRAPHIC FINDINGS IN SUBJECTS WITH AN AMYLOIDOGENIC APOLIPOPROTEIN A1 MUTATION (2022) (0)
P597Clinical and prognostic correlates of volume/time curve at cardiac magnetic resonance in patients with non-ischemic heart failure and left bundle branch block (2019) (0)
790 LEFT VENTRICULAR OUTFLOW TRACT VELOCITY TIME INTEGRAL OUTPERFORMS LEFT VENTRICULAR EJECTION FRACTION IN HEART FAILURE PATIENTS WITH SIGNIFICANT MITRAL REGURGITATION (2022) (0)
[Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC)]. (2021) (0)
Reverse remodelling, changes in diastolic function and their prognostic value compared to natriuretic peptides (2020) (0)
Tissue Characterization in Cardiac Amyloidosis (2022) (0)
38 Increased peripheral and central chemosensitivity in heart failure: a hidden pathogenetic trigger with an independent prognostic value (2008) (0)
Sex-related differences in daytime Cheyne-Stokes respiration in heart failure (2021) (0)
1099 ERGOREFLEX SENSITIVITY IS ASSOCIATED WITH CARDIAC INVOLVEMENT IN BECKER MUSCULAR DYSTROPHY (2022) (0)
267 EFFECTS OF PIRFENIDONE ON SCAR SIZE AND VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION: A PRECLINICAL STUDY (2022) (0)
Post-Mortem Cardiac Magnetic Resonance in Explanted Heart of Patients with Sudden Death (2022) (0)
Wednesday, 29 August 2012 (2012) (0)
Angiotensin II radioimmunoassay in patients with heart failure: methodological and clinical assessment (2004) (0)
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction. (2022) (0)
NT-PROBNP DURING SCREENING IN THE STUDY OF VERICIGUAT IN PARTICIPANTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL: INSIGHTS INTO OUTCOMES AND VERICIGUAT (2023) (0)
Glycometabolic imbalance is a main determinant of neurohormonal activation and cardiac mortality in mild systolic heart failure (2012) (0)
Circulating levels of cardiac troponin-I are age and gender dependent in healthy subjects (2009) (0)
[An atypical case of cardiac amyloidosis]. (2009) (0)
Development of an Electronic Medical Record System for the Department of Cardiology (1997) (0)
Abstract 14182: Myocardial Fibrosis and Reverse Remodelling in Nonischaemic Dilated Cardiomyopathy (2015) (0)
Are spectral estimates of heart rate variability dependent on heart rate? a formula to correct when needed (2001) (0)
324Prognostic role of late gadolinium enhancement in patients with low or intermediate HCM SCD risk score: a multicenter study (2019) (0)
[Usefulness, timing and modality of ECG stress testing after myocardial revascularization]. (2018) (0)
Editorial Comment Targeting Periodic Breathing in Heart Failure Patients, and Treating ItdGently (2014) (0)
Abnormal chemoreflex sensitivity to hypoxia and hypercapnia predictors in chronic heart failure (2013) (0)
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets. (2018) (0)
Diabetes is a predictor of effort tolerance and ventilatory efficiency in patients with moderate systolic dysfunction on beta-blocker therapy (2010) (0)
BIOMARKERS OF MUSCLE AND HEART DAMAGE IN PATIENTS WITH MITOCHONDRIAL DISEASE (2016) (0)
Serumgamma-glutamyltransferase fractions inMyotonic Dystrophy type I: Differences with healthy subjects and patients with liver disease (2010) (0)
Epicardial adipose tissue, infarct size, microvascular obstruction and ventricular remodelling after ST-segment elevation myocardial infarction (2022) (0)
[Plasma ultrafiltration]. (1988) (0)
Immunoradiometric assay of serum myosin as a marker of myocardial cell damage: methodological and clinical evaluation. (1993) (0)
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance (2020) (0)
OVEREXPRESSION OF ANG-(1-7) IMPROVES CARDIAC FUNCTION AND ATTENUATES LEFT VENTRICULAR REMODELING: PP.1.10 (2010) (0)
501 Investigating the epidemiology of cardiac amyloidosis: design of the ‘cardiac amyloidosis registry’ (CARRY) (2021) (0)
Gender and age normalization and ventilation ef ﬁ ciency during exercise in heart failure with reduced ejection fraction (2019) (0)
These abstracts have been selected for VIEWING only as ePosters and in print. ePosters will be available on Screen A & B throughout the meeting, Print Posters at the times indicated below. Please refer to the PROGRAM for more details (2014) (0)
P4710Quality of life and left atrial function in patient with chronic heart failure: the echocardiographic multicentric FLASH study (2018) (0)
Distribution od cTnI values in a large population of adult healthy subjects (2007) (0)
Cardiac magnetic resonance findings in patients with type 1 myotonic dystrophy (2021) (0)
Targeting precipitants to prevent heart failure hospitalization. Does season matter? (2022) (0)
Searching for diagnostic biomarkers of heart failure with preserved ejection fraction: methodological issues (2020) (0)
Analytical performance of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP (2009) (0)
[From loss to prevention: lessons to be learned from juvenile sudden death]. (2022) (0)
P363 HIGH–SENSITIVITY TROPONINS FOR OUTCOME PREDICTION IN THE GENERAL POPULATION: A SYSTEMATIC REVIEW AND META–ANALYSIS (2022) (0)
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? (2018) (0)
ASSOCIATION BETWEEN BLOOD PRESSURE VARIABILITY, CARDIOVASCULAR DISEASE AND ALL-CAUSE MORTALITY IN TYPE 2 DIABETES (2019) (0)
Prognostic Signi ﬁ cance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure (0)
Relation between myocardial oedema and cocaine assumption in heavy-user asymptomatic cocaine addicts (2013) (0)
Oral Abstract Session: Prolonged rhythm monitoring for detection of atrial fibrillation (2013) (0)
P4571PFA-100, a test of platelet adhesion/aggregation, predicts cardiovascular events after an acute coronary syndrome and can help in the decision-making for dual antiplatelet extension (2019) (0)
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy (2023) (0)
CMR predictors of secondary moderate to severe mitral regurgitation and its additive prognostic role in previous myocardial infarction. (2021) (0)
SYMPATHETIC RENAL DENERVATION AFTER ACUTE MYOCARDIAL INFARCTION BLUNTS ADRENERGIC ACTIVATION AND INCREASED MYOCARDIAL SALVAGE IN PIGS (2018) (0)
Heterogeneity of right ventricular refractory period: a novel prognostic predictor in type-1 Brugada (2021) (0)
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation (2022) (0)
Physiological regularity of cardiovascular and spontaneous respiration series in healthy humans (2001) (0)
502 Beta cell function (insulin secretion) is impaired in patients with stable chronic heart failure (2004) (0)
The importance of breathing not properly: Chronic obstructive pulmonary disease as a risk factor for rehospitalization in heart failure. (2019) (0)
P3515Gender differences in plasma levels and prognostic value of NT-proBNP in chronic heart failure (2019) (0)
Prognostic impact of echocardiographic derived precapillary wedge pressure and pulmonary vascular resistances in patients with heart failure (2022) (0)
500 Short‐time versus long‐time ambulatory recording by a cardio‐respiratory wearable device for detection of Cheyne‐Stokes respiration in heart failure (2004) (0)
P5658Neurohormonal activation across categories of systolic function in chronic heart failure (2018) (0)
Diagnostic Pathways to Wild-Type Transthyretin Amyloid Cardiomyopathy: a Multicenter Network Study. (2023) (0)
High-risk NSTEMI due to Subclavian Artery Atherothrombosis in a Prior Coronary Artery Bypass Graft Patient (2019) (0)
Abstract 19039: Prediction of the Chemoreflex Sensitivity by Common Clinical Variables in Systolic Heart Failure (2014) (0)
544 Cardiac natriuretic hormones are related to neuro-hormones and stress-activated cytokines in patients with heart failure (2003) (0)
Effect of acute administration of vitamin C on muscle sympathetic activity , cardiac sympathovagal balance , and baroreflex sensitivity in hypertensive patients 1 – 3 (2012) (0)
Heart rate variability at high level (1993) (0)
PROCEEDINGS of the XVI CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Lecce, Italy June 8-11, 2016 (2016) (0)
Prognostic value of NT-proBNP and best cut-offs for risk prediction in obese patients with chronic systolic heart failure (2020) (0)
PROCEEDINGS of the XVI CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Lecce, Italy June 8-11, 2016 (2016) (0)
Intact broblast growth factor 23 tested by a fully automated assay: clinical correlates and prognostic value in chronic systolic heart failure (2022) (0)
Cardiac magnetic resonance in pericardial disease (2015) (0)
Uncommon ECG presentation in Tako-tsubo syndrome (2021) (0)
SEX DIFFERENCES IN PLASMA CONCENTRATIONS AND PROGNOSTIC VALUE OF NT-PROBNP IN CHRONIC HEART FAILURE (2019) (0)
676 Additive prognostic value of fT3 and BNP in heart failure patients (2007) (0)
Abstract 17979: Prognostic Value of Aldosterone Breakthrough in Systolic Heart Failure Patients (2013) (0)
Total least squares modelling of cardiovascular time series (1995) (0)
ARTERIAL STIFFNESS AND REMODELING FROM LARGE TO SMALL ARTERIES IN PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION (2019) (0)
500 HEMODYNAMIC FORCES AS PREDICTORS OF CARDIAC REMODELING AND OUTCOME IN PATIENTS WTH HEART FAILURE WITH REDUCED EJECTION FRACTION TREATED WITH SACUBITRIL/VALSARTAN (2022) (0)
Evaluation of the analytical perfroamnce of a novel immunoenzymometrci assay for brain natriuretic peptide (2013) (0)
[Biomarkers for the diagnosis and management of heart failure: natriuretic peptides]. (2021) (0)
Giant Intrapericardial Hemangioma: Diagnostic Value of Cmr. (2013) (0)
Soluble and cell bound gamma-glutamyltransferase activity – factors in LDL peroxidation, atherogenesis and cardiovascular disease (2005) (0)
679 PROGNOSTIC IMPACT OF ECHOCARDIOGRAPHIC DERIVED PRECAPILLARY WEDGE PRESSURE AND PULMONARY VASCULAR RESISTANCES IN PATIENTS WITH HEART FAILURE (2022) (0)
Haemodynamic forces as predictors of cardiac remodelling and outcome in heart failure with reduced ejection fraction treated with sacubitril/valsartan (2022) (0)
484 Echocardiographic patterns in patients with apolipoprotein AI amyloidosis (2021) (0)
CHEMOREFLEX AND BAROREFLEX DYSFUNCTION IN CHRONIC HEART FAILURE: CLINICAL CORRELATES AND PROGNOSTIC SIGNIFICANCE (2021) (0)
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis (2023) (0)
P2728Prognostic impact of left atrial function in patients with cardiac amyloidosis: a cardiac magnetic resonance study (2019) (0)
P595Risk scores or NT-proBNP for prognostic stratification of heart failure patients? (2017) (0)
Plasma γ-glutamyltransferase fractions: diagnostic and prognostic predictive value (2010) (0)
584 Circulating adrenomedullin levels and Doppler-derived dP/dt in idopathic cardiomyopathy (2003) (0)
Comparison of analytical performance and diagnostic accuracy of BNP and NT-proBNP immunoassays (2005) (0)
[Adrenergic activation in heart failure: blockade or rebalance?]. (2010) (0)
PREDICTORS OF CARDIAC MAGNETIC RESONANCE-ASSESSED REVERSE REMODELING IN NON-ISCHEMIC DILATED CARDIOMYOPATHY (2016) (0)
Abstract 15666: The Mecki Score: A More Accurate Prognostic Tool in Patients With Heart Failure. A Multicenter Comparison With Shfm and Hfss in a Large Cohort of Patients (2016) (0)
38G single-nucleotide polymorphism at the KCNE1 locus is ssociated with heart failure (0)
C63 PHENOTYPE – GENOTYPE RELATIONSHIP IN ARRHYTHMOGENIC CARDIOMYOPATHY (2022) (0)
Performance and diagnostic accuracy of BNP and Nt-proBNP immunoassay evaluated following EBLM principles (2004) (0)
Is There Still A Need for Treatment of Central Apnea , After the SERVE-HF Trial ? (2015) (0)
Pattern complexity and nonlinear dynamics in RR-sequences (2002) (0)
541 Prevalence of amyloid transthyretin cardiomyopathy in elderly subjects from the general population: first results from the catch study (2021) (0)
BNP immunoassay: comparison of a fully automated method with a POCT technique (2005) (0)
439 Clinical improvement after biventricular pacing is best matched with decrease in brain natriuretic peptide in heart failure patients (2004) (0)
P4681Exercise-induced myocardial edema in master triathletes: insights from cardiovascular magnetic resonance imaging (2018) (0)
186A novel echo-doppler approach for quantitative estimation of pulmonary artery wedge pressure and pulmonary vascular resistances (2018) (0)
TCT-421 Renal denervation in hypertensive patients: effects on neurohormonal activation and cardiac natriuretic peptides (2014) (0)
Nonlinear Analysis of Heartbeat Time Series (1996) (0)
B-type plasma natriuretic hormone level in operated Fallot patients (2006) (0)
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE: PP.1.08 (2010) (0)
High-Sensitivity Troponins and Prognosis in Heart Failure: Which Kind of Meta-Analysis Is Needed? (2018) (0)
Ventricular repolarization is prolonged in nondipper hypertensive patients: role of autonomic dysfunction and left ventricular hypetrophy (2003) (0)
Heart rate variability changes in acute myocardial infarction (2000) (0)
Psychosocial, cognitive and functional characterization of patients with advanced heart failure (0)
298 Atrial fibrillation and amino‐terminal pro‐brain natriuretic peptide as independent predictors of prognosis in systolic heart failure (2008) (0)
A NOVEL MARKER OF PROGRESSION FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES: SERUM GAMMA-GLUTAMYLTRANS- FERASE ENZYME ACTIVITY (2008) (0)
664 Low T3 syndrome in chronic heart failure: relation with A- and B-type natriuretic peptide expression and prognostic value (2005) (0)
[Transcatheter devices for chronic heart failure: state of the art]. (2022) (0)
Exercise tolerance is depending directly on coronary reserve and inversely on rate-pressure product response to exercise in hypertensive patients without myocardial ischemia. (1999) (0)
The month after a novel tale on eplerenone, but with a different ending. (2011) (0)
478 Personality factors influencing quality of life in patients with heart failure: a linkage with neurohormonal activation (2003) (0)
Myocardial fibrosis in nonischemic dilated cardiomyopathy: role of increased wall stress and neurohormonal activation (2010) (0)
Serum and tissue light-chains as disease biomarkers and targets for treatment in AL amyloidosis (2022) (0)
TCT-560 Sympathetic Renal Denervation After Acute Myocardial Infarction Results in Increased Myocardial Salvage in Pigs (2018) (0)
Coronary reserve is already reduced, and minimum coronary resistance increased, in patients with borderline arterial hypertension (1999) (0)
Hypnosis modifies the sympathetic-parasympathetic balance (1993) (0)
Gamma-glumamyl-transferase levels are associated with inflammatory activation, myocardial dysfunction and mortality in pateints with ST-elevation myocardial infarction (2013) (0)
262 Changes in ultrasound lung comets as a guide to treatment in heart failure patients: correlation with NT-proBNP (2005) (0)
N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE VERSUS CLINICAL RISK SCORES FOR PROGNOSTIC STRATIFICATION IN HEART FAILURE PATIENTS (2018) (0)
[Cheyne-Stokes respiration and heart failure: pathophysiological and clinical implications]. (2009) (0)
Interactions in Atherosclerosis Serum Gamma-Glutamyltransferase and Intima-Media Thickness: Pointing Again to Wall/Lumen (2012) (0)
Overlapping effects of miR-21 inhibition and drugs for idiopathic pulmonary fibrosis in the post-myocardial infarction setting (2021) (0)
645 Increased chemoceptive sensitivity to carbon dioxide during Cheyne‐Stokes respiration in chronic heart failure is associated with adrenergic and cardiac natriuretic hormone (2006) (0)
Exploring the supra linear relationship between PetCO2 and fMRI signal change with ICA (2019) (0)
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI. (2023) (0)
P215 Effects of ARNI therapy on left atrial and ventricular longitudinal deformation and functional capacity in HFrEF patients (2020) (0)
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox. (2018) (0)
604 Comparison of analytical performances and diagnostic accuracy of a fully automated immunoassay and a POCT method for BNP assay (2005) (0)
NT-PROBNP PREDICTS MORTALITY IN ELDERLY AND VERY ELDERLY PATIENTS WITH CHRONIC SYSTOLIC HEART FAILURE (2018) (0)
Breath hold task induces temporal heterogeneity in electroencephalographic regional field power in healthy subjects. (2020) (0)
Mismatch between mRNA cardiac expression of BNP and CNP in pacing-induced heart failure. (2009) (0)
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods (2006) (0)
Comparison between IRMA and chemiluminescence BNP immunoassay in patients with congestive heart failure (2003) (0)
Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry. (2023) (0)
Deep learning to diagnose cardiac amyloidosis from CMR findings (2020) (0)
470 Coronary microvascular impairment is related to increased plasma levels of osteopontin in patients with idiopathic left ventricular dysfunction (2008) (0)
AB0683 Troponin Might be a Candidate Marker for Subclinical Scleroderma Heart Involvement (SHI): A Preliminary Report (2015) (0)
Abstract 18963: Clinical Significance of Daytime Vs. Nighttime Cheyne-stokes Respiration in Systolic Heart Failure Patients: Findings From 24- Hour Polygraphic Recordings (2014) (0)
417 Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis (2021) (0)
279 Medical treatment with ARNI may reduce indications for primary prevention of sudden cardiac death in heart failure with reduced ejection fraction: insights from discover-ARNI, a multicentre Italian register (2021) (0)
Cardiac involvement in creatine deficiency syndrome (2022) (0)
Twenty-four hour assessment of respiratory variability by ambulatory monitoring with a piezoelectric transducer (1993) (0)
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? (2019) (0)
Hide and seek. Ticagrelor and central apneas after acute coronary syndrome. (2021) (0)
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients (2007) (0)
The Heart Complexity The Intrinsic Function (Intrinsic Regulation of Heart Rate and Mechanics) (2006) (0)
Microcirculatory dysfunction and sympathetic hyperthonus in systemic sclerosis: a study by skin laser doppler and RR interval power spectrum analysis (1997) (0)
Abnormal coronary microcirculatory resistance is already present in borderline high blood pressure (1999) (0)
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning. (2022) (0)
PLASMA RENIN ACTIVITY AND ANGIOTENSINOGEN M235T POLYMORPHISM ARE DETERMINANTS OF ALDOSTERONE ESCAPE IN PATIENTS WITH SYSTOLIC HEART FAILURE (2011) (0)
Moderated posters (2001) (0)
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning (2022) (0)
Real-time Dynamic CO2 Administration: A Novel Treatment Strategy For Periodic Breathing (2010) (0)
Tireless cardiologists needed for (very) tired patients: The case of heart failure (2018) (0)
24 hour heart rate variability and denervation in cardiac chagas' disease (1993) (0)
These abstracts have been selected for presentation in 4 sessions throughout the meeting. Please refer to the PROGRAM for more details. (2014) (0)
578 Analytical and clinical performance of NT-proBNP immunoassay (2003) (0)
Serum myosin as marker of myocardial cell damage: methodological and clinical evaluation of a new immunometric assay (1992) (0)
Behind enemy lines: How to enlarge heart transplant criteria. (2019) (0)
ERGOREFLEX OVERACTIVITY: A POTENTIAL CAUSE OF EXERCISE LIMITATION AND DYSAUTONOMIA IN PATIENTS WITH MITOCHONDRIAL MYOPATHY (2016) (0)
Association of eNOS Glu298Asp polymorphism with cardiometabolic risk and inducible myocardial ischemia in patients with stable coronary artery disease (2022) (0)
Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation. (2020) (0)
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case (2011) (0)
The role of 18FDG PET/CT in the assessment of endocarditis, myocarditis and pericarditis. (2020) (0)
Unilateral Adrenal Hyperplasia in the Presence of a Reninoma in a Young Pregnant Woman. (2020) (0)
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis (2020) (0)
Humoral evaluation of endothelial function: focus on CNP (2006) (0)
[Ambulatory electrocardiography in patients with angina pectoris]. (1987) (0)
Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis (2021) (0)
Comparison of two BNP immunoassays using the same antibodies and standard materials (2005) (0)
Prognostic complexity of heart failure and network analysis: the holistic risk stratification (2010) (0)
313 Circulating antibodies to heat shock protein 65 in patients with heart failure (2003) (0)
Interactions of ventilation and arousal oscillations in patients with Cheyne-Stokes respiration (2008) (0)
Differences in family caregiver experiences and expectations of end-of-life heart failure care across providers and settings: a systematic literature review (2023) (0)
626 Day‐time Cheyne‐Stokes respiration and plasma B‐type natriuretic peptide elevation in heart failure patients: incremental prognostic value (2006) (0)
1111 INTACT FIBROBLAST GROWTH FACTOR 23 TESTED BY A FULLY AUTOMATED ASSAY: CLINICAL CORRELATES AND PROGNOSTIC VALUE IN CHRONIC SYSTOLIC HEART FAILURE (2022) (0)
266 Deformation imaging by strain in chronic heart failure over sacubitril–valsartan: a multicentre echocardiographic registry (discover)—ARNI (2021) (0)
Partial Lipodystrophy and LMNA p.R545H Variant (2021) (0)
Analysis of generic coupling between EEG activity and PETCO2 in free breathing and breath-hold tasks using Maximal Information Coefficient (MIC) (2018) (0)
773 Increased chemosensitivity to hypoxia and hypercapnia is associated with right ventricular function in heart failure patients (2007) (0)
Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity (2012) (0)
974 SACUBITRIL-VALSARTAN AMELIORATES MITOCHONDRIAL FUNCTION IN A MURINE MODEL OF ISOPROTERENOL-INDUCED LEFT VENTRICULAR DYSFUNCTION (2022) (0)
Plasmatic levels of cardiac natriuretic hormones in healthy adults: effects of age and sex (2002) (0)
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure (2005) (0)
Myocardial ischemia, coronary reserve, LV geometry and arterial capacitance in essential hypertension (2002) (0)
[Isosorbide dinitrate ointment in the long-term treatment of intermittent claudication]. (1984) (0)
Troponin in nonischemic dilated cardiomyopathy: a marker of irreversible myocardial remodeling and fibrosis (2010) (0)
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration (2010) (0)
The role of C-type natriuretic peptide in the heart: study in an experimental model of pacing-induced heart failure (2007) (0)
Sex‐related difference in sympathetic chemoreflex response: does it matter in clinical disease? (2022) (0)
632 Diagnostic and prognostic performance of HFA-PEFF and H2FpEF scores in patients with cardiac amyloidosis (2021) (0)
Relative hypochromia in acute heart failure to predict outcome and guide treatment: Ready for prime time? (2019) (0)
2059Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure (2017) (0)
Valve disease in cardiac amyloidosis: an echocardiographic score (2022) (0)
Serum γ-glutamiltransferase: A new factor in atherosclerotic plaque progression? (2005) (0)
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators. (2017) (0)
276 CIRCULATING FORMS OF PLASMA TRANSTHYRETIN IN PATIENTS WITH WILD-TYPE TRANSTHYRETIN AMYLOIDOSIS AND EFFECTS OF TREATMENT WITH TAFAMIDIS (2022) (0)
CORRELATION BETWEEN DIFFERENT MEASURES OF CARDIOVASCULAR AUTONOMIC REGULATION IN ESSENTIAL HYPERTENSION: PP.32.262 (2010) (0)
Myocardial fibrosis as a early cardiac marker of disease in patients with lamin A/C mutations (2011) (0)
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers (2022) (0)
Cardiac Biomarkers in the Emergency Department : the role of sST 2 in acute heart failure and acute coronary syndrome-There is meat on the bone (2019) (0)
Two common echocardiographic variables to diagnose cardiac amyloidosis: the AMYLoidosis Index (AMYLI) score (2020) (0)
Impact of rate versus rhythm control strategy on left ventricle function in patients with persistent atrial fibrillation, one year follow-up (2015) (0)
[The prognostic role of gamma-glutamyltransferase for cardiovascular events]. (2006) (0)
Regional cardiac expression of biomarkers involved in apoptotic process in an experimental model of left ventricular pacing-induced heart failure (2010) (0)
602 Right heart overload is the main determinant of BNP elevation in patients with heart failure: a magnetic resonance study (2003) (0)
Coronary Macro- and Microcirculatory Response to Adenosine and Isosorbide Dinitrate in Patients with Chest Pain and Risk Factors for Ischemic Heart Disease: A TEE Study (1996) (0)
Cardio-renal scintigraphy with 99mTc-tetrofosmin: Feasibility and preliminary results in cardiovascular patients (2007) (0)
Voltage Gradient Dispersion Mapping in Asymptomatic Subjects with Brugada Type-1 Electrocardiographic Pattern (2022) (0)
Breathless Heart: Final Remarks (2017) (0)
Pirenzepine, a M1 antimuscarinic agent, increases heart rate variability in patients with ischemic heart disease (1993) (0)
N-terminal fragment of brain natriuretic peptide predicts vascular health and subclinical atherosclerosis: results from MEHLP study (2012) (0)
Left atrial strain in cardiac amyloidosis (2021) (0)
Ventricular repolarization in hypertension: beyond Bazett. (2008) (0)
Relationships between cardiac pain and objective markers of transient myocardial ischemia. (1989) (0)
Prognostic value of cardio-pulmonary exercise testing in cardiac amyloidosis (2021) (0)
mICA-Based fMRI Analysis of Specific CO2-Level-Dependent BOLD Signal Changes in the Human Brainstem (2023) (0)
[Natriuretic peptides in heart failure]. (2006) (0)
Obstructive Sleep Apnoea and Hypoxia in Precapillary Pulmonary Hypertension: Prevalence, Determinants and Daytime Clinical, Respiratory and Cardiac MRI Correlates (2020) (0)
P4025Sympathetic renal denervation after acute myocardial infarction results in increased myocardial salvage in pigs (2017) (0)
C42 MULTI–CHAMBER SPECKLE TRACKING IMAGING AND DIAGNOSTIC VALUE OF LEFT ATRIAL STRAIN IN CARDIAC AMYLOIDOSIS (2022) (0)
P5848Different features of cardiac involvement in patients with AL vs. TTR amyloidosis (2017) (0)
P2974Late gadolinium enhancement, reverse remodeling and prognosis in patients with non-ischemic dilated cardiomyopathy and moderate-to-severe systolic dysfunction (2017) (0)
Evaluation of the expression of transcripts coding for CNP and for its specific receptor NPR-B by Real Time PCR in cardiac tissue of normal and heart failure animals (2008) (0)
Clinical management of drug-induced cardiotoxicity in patients with HER-2+ breast cancer: current recommendations and future outlook (2023) (0)
16-74: Prognostic impact of QRS axis deviation in patients treated with cardiac resynchronization therapy (2016) (0)
Historical Background and Book Aim (2006) (0)
Chronic obstructive pulmonary disease in heart failure: influence on circulating biomarkers and outcome (2020) (0)
419 High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis (2021) (0)
Death occurred due to undiagnosed systemic amyloidosis: a case report. (2022) (0)
Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction (2021) (0)
Nifedipine Infusion in Unstable Angina: A Single-Blind, Double-Crossover, Placebo-Controlled Holter Study (1991) (0)
Coronary Pressure Flow Diagrams as Assessed by Transesophageal Echo Doppler of Left Anterior Descending Artery in Presence and Absence of Left Ventricular Hypertrophy (1994) (0)
Pediatric Age and the Ontogeny of the Brain and Heart Connection (2020) (0)
Pacing and resynchronization therapy CHADS 2 and CHA 2 DS 2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy (2013) (0)
91 Overlapping effects of MI-R-21 inhibition and oral anti-fibrotic and anti-inflammatory drugs: rationale for drug repurposing to relieve ischemia/reperfusion injury (2020) (0)
275 Ultrasound lung comet as a bedside sign of cardiogenic dyspnea (2005) (0)
462 RELATIONSHIP BETWEEN PATIENT GENOTYPE, VENTRICULAR INVOLVEMENT AND SUDDEN CARDIAC DEATH IN PATIENTS WITH ARRHYTHMOGENIC CARDIOMYOPATHY (2022) (0)
Stroke in ATTR cardiac amyloidosis: does rhythm only matter? (2022) (0)
N-terminal fragment of brain natriuretic peptide as a powerful and independent predictor of subclinical heart and vascular disease (stage B) in an asymptomatic population from the community screening (2013) (0)
60 Prognostic value of plasma NT‐proBNP level at discharge after levosimendan treatment in acute/decompensated heart failure (2006) (0)
704 Recurrence quantification analysis describe the complex and deterministic behavior of heart rate variability in healthy subjects: Link with susceptibility to hypnosis (1998) (0)
[Imaging the innervation of the failing heart]. (2012) (0)
Aldosterone and excessive daytime sleepiness in myotonic dystrophy (2008) (0)
QTc lenghtening is associated to sympathetic predominance throughout the 24 hour period in recent onset hypertension (1999) (0)
Intact fibroblast growth factor 23 tested by a fully automated assay: clinical correlates and prognostic value in chronic systolic heart failure (2022) (0)
The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis? (2021) (0)
Reverse remodelling criteria to predict cardiovascular death in heart failure with reduced or mid-range ejection fraction (2021) (0)
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is (2022) (0)
How a large registry can explain pathophysiology: The case of anemia in the heart failure syndromes. (2019) (0)
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues (2018) (0)
269 EFFECTS OF COLCHICINE TREATMENT AFTER MYOCARDIAL INFARCTION ON TOP OF STANDARD THERAPY: EVIDENCE FROM A PRECLINICAL STUDY (2022) (0)
DISCORDANT VERSUS CONCORDANT T-WAVE IN LEFT BUNDLE BRANCH BLOCK PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY (2011) (0)
Global warming, renal function and heart failure: a 20-year follow-up study (2022) (0)
Time frequency dynamics of Valsalva manoeuvre and short transient autonomic testing (1993) (0)
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome. (2022) (0)
Artificial intelligence applied to non-contrast-enhanced cardiac computed tomography for the prediction of cardiovascular events (2020) (0)
Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy. (2022) (0)
297 Echocardiographic biventricular coupling index to predict pre-capillary pulmonary hypertension (2021) (0)
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. (2014) (0)
Biomarker‐guided management in acute heart failure: is there light at the end of the tunnel? (2019) (0)
Myocardial damage after subarachnoid hemorrhage (1993) (0)
Lipids, glutathione and other key players in Redox cardiology (2009) (0)
[Increase in tolerance to physical effort in patients with X syndrome after acute administration of aminophylline]. (1989) (0)
Prognostic relevance of plasma aldosterone during renin-angiotensin-aldosterone system inhibition in heart failure patients (2012) (0)
ECG devices interoperability in hospital environment: clinical experience (2004) (0)
Response to the Letter: Sleep-Disordered Breathing in Precapillary Pulmonary Hypertension: Is the Prevalence So High? Reference Article: Sleep-Disordered Breathing and Nocturnal Hypoxemia in Precapillary Pulmonary Hypertension: Prevalence, Pathophysiological Determinants and Clinical Consequences by (2021) (0)
[Biomarkers for the diagnosis and management of heart failure: new frontiers]. (2021) (0)
Pressure–volume relationship by pharmacological stress cardiovascular magnetic resonance (2021) (0)
67 Echocardiography vs. computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis (2020) (0)
Influence of Sca I and Natriuretic Peptide ( NP ) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure (2007) (0)
New techniques to assess autonomic cardiovascular regulation. (1996) (0)
Analytical performance of cardiac troponin –I assays for the AxSYM plarform: comparison with the old method and Assess system (2006) (0)
The clinical diagnosis of heart failure is predicted by neurohormonal and immune derangement (2003) (0)
P241 CARDIAC INVOLVEMENT IN CREATINE DEFICIENCY SYNDROME (2022) (0)
Wild type transthyretin amyloidosis: Don't miss diagnosis! (2020) (0)
Cardiac magnetic resonance: evaluation of signal intensity decay after the injection of gadolinium in cardiac amyloidosis (2013) (0)
506 Day‐time Cheyne‐Stokes respiration is associated with adrenergic activation and increase in A‐type and B‐type natriuretic hormones in chronic heart failure (2005) (0)
Beyond phrenic nerve stimulation to reduce the hypoxemic burden in central apneas: Targeting chemoreflex? (2023) (0)
472 Feasibility of home telemonitoring of vital signs and cardiorespiratory signals in chronic heart failure patients: preliminary results from the HHH study (2005) (0)
Relationship between reduced exercise tolerance and cardiac functional and structural factors in hypertensive patients without coronary artery disease (2001) (0)
Race/ethnicity and plasma NT-proBNP in black and white individuals: How it matters. (2019) (0)
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays (2012) (0)
Prognostic role of cardiovascular magnetic resonance in nonischaemic dilated cardiomyopathy (2012) (0)
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis (2022) (0)
PROGNOSTIC IMPACT OF DISCORDANT VERSUS CONCORDANT LEFT BUNDLE BRANCH BLOCK IN HEART FAILURE PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY (2013) (0)
Time-dependent analysis of autonomic tests: A method based on wigner-ville power spectral density estimation (1997) (0)
Human Vulnerable Carotid Plaques Show High Levels of b-Gamma-glutamyl Transferase Enzyme Activity. (2014) (0)
Exercise Oscillatory Ventilation in Heart Failure and Brain-Lung-Heart-Muscle Crosstalk. (2022) (0)
How much is it to mend a broken heart? Results from the US Nationwide Readmission Database. (2020) (0)
582 Plasma levels of adrenomedullin, big-endothelin-1 and osteopontin in chronic heart failure (2003) (0)
465 Unmasking the prevalence of cardiac amyloidosis in the real world: first insights from the phase 2 of active study, an Italian nationwide survey (2021) (0)
P4706Phase-related variations in cardiopulmonary hemodynamics throughout cheyne-stokes respiration in patients with heart failure (2018) (0)
737 CLINICAL AND PROGNOSTIC SIGNIFICANCE OF LEFT VENTRICULAR OUTFLOW TRACT VELOCITY TIME INTEGRAL (LVOT-VTI) IN PATIENTS WITH CHRONIC HEART FAILURE (2022) (0)
Correction to: Validity of transit time–based blood pressure measurements in patients with and without heart failure or pulmonary arterial hypertension across different breathing maneuvers (2020) (0)
Prevalence and persistence of breathing disorders in chronic heart failure patients: preliminary results from home telemonitoring in the HHH study (2005) (0)
Prognostic value of cardiac fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure: a multicentre magnetic resonance study (2014) (0)
P2538Arterial stiffness and remodeling from large to small arteries in patients with spontaneous coronary artery dissection: evidence for a systemic subclinical involvement (2019) (0)
Relationship between exercise tolerance and coronary reserve in hypertensive patients with angiographically normal coronary artery (1999) (0)
Cardiac magnetic resonance: late gadolinium enhancement for risk stratification of patients with cardiac amyloidosis (2013) (0)
557 RAREFACTION OF MYOCARDIAL LYMPHATIC VESSELS IN PATIENTS WITH CARDIAC AMYLOIDOSIS (2022) (0)
Central apneas and Ticagrelor related dyspnea in patients with acute coronary syndrome (2020) (0)
P995The extent of late gadolinium enhancement predicts defibrillator shocks in patients with non-ischaemic heart failure (2019) (0)
Novel Drug Targets for Central Apneas in Heart Failure: On the Road (2021) (0)
Central and obstructive apneas prevalence in heart failure with reduced, mid-range and preserved ejection fraction (2020) (0)
P4499Prognostic role of myocardial edema at cardiac magnetic resonance in hypertrophic cardiomyopathy (2017) (0)
Real-Time Dynamic Carbon Dioxide Administration Reply (2011) (0)
Exploratory analysis of nonlinear coupling between EEG global field power and end-tidal carbon dioxide in free breathing and breath-hold tasks. (2016) (0)
Immunoassay in neuro-hormonal characterisation of heart failure (2004) (0)
Sacubitril/valsartan improves ventilation stability in patients with chronic heart failure (2020) (0)
cTnI values of adult healthy subjects obtained using a highly sensitive immunoassay (2007) (0)
MYOCARDIAL REMODELLING AND FIBROSIS IN NONISCHAEMIC DILATED CARDIOMYOPATHY: INSIGHTS FROM CARDIOVASCULAR MAGNETIC RESONANCE (2016) (0)
Non-linear dynamics of repiration (1992) (0)
92 Osteopontin plasma levels are elevated in patients with chronic heart failure in relation to clinical severity and cytokine expression (2004) (0)
409 Circulating antibodies to heat shock proteins and biomarkers in patients with heart failure (2004) (0)
[Rationale and significance of the Italian Network for Cardiac Amyloidosis]. (2023) (0)
High prevalence of myocardial damage evaluated by cardiovascular magnetic resonance in asymptomatic subject with cocaine addiction (2010) (0)
Cardiac natriuretic hormones as clinical markers: instructions for use. (2006) (0)
Ratio between left and right ventricular end-diastolic volumes and outcomes in patients with heart failure and preserved ejection fraction (2022) (0)
Aspirin and Prognosis in Heart Failure: A Question of Power. (2018) (0)
Relationships between transient myocardial ischermia, pain and ventricular tachyarrhythmias (1989) (0)
Abstract 20350: Discordant Left Bundle Branch Block is Associated With Left Ventricular Dyssyncrhony at Cardiac Magnetic Resonance Imaging in Patients With Nonischemic Cardiomyopathy (2014) (0)
778 The prognostic role of interleukin‐6 and Tumor Necrosis Factor‐alpha in chronic heart failure (2005) (0)
A Workstation for Clinical Decision Support in a Local Area Network for Cardiology (1995) (0)
When chronic heart failure intersects chronic obstructive pulmonary disease: impact on long-term prognosis (2011) (0)
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population). (2022) (0)
Abstract P217: Cardiac Involvement In Creatine Deficiency Syndrome: From Transgenic Model To Humans (2022) (0)
646 Plasma renin activity is an independent prognostic factor in heart failure patients (2008) (0)
P1653Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure (2019) (0)
Plasma ANP and BNP levels measured by highly sensitive and specific immuno-radiometric assay in patients with heart failure (1997) (0)
Coronary flow reserve: a new target for treating hypertension (2009) (0)
Fractions of Gamma-Glutamyltransferase in healthy individuals, alcohol addicts and patients with hepatic disease (2008) (0)
P444Effect of sex on reverse remodelling in chronic systolic heart failure (2017) (0)
Plasma renin activity is an independent prognosticator in heart failure patients with kidney disease (2010) (0)
[Cardiomyopathy and hypereosinophilia: a post-partum case]. (2009) (0)
Letter by Aimo et al Regarding Article, "Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies". (2019) (0)
PROGNOSTIC RELEVANCE OF LEFT VENTRICULAR EJECTION FRACTION AND THE 40% CUT-OFF IN CHRONIC SYSTOLIC HEART FAILURE (2018) (0)
P294 AN ECHOCARDIOGRAPHIC SCORE OF VALVE DISEASE IN PATIENTS WITH CARDIAC AMYLOIDOSIS (2022) (0)
Heterogeneous cardiac response to high dose dobutamine magnetic resonance stress test in patient with left ventricular dysfunction (2009) (0)
Novel LMNA gene mutation in a patient with cardiac and skeletal muscle involvement (2009) (0)
Estimation of cardiac aging by CT imaging: towards the definition of new cardiovascular biomarkers using a deep learning approach. (2020) (0)
212 Endothelium-dependent and independent vasodilation is impaired at peripheral microcirculatory level in patients with coronary artery disease (1999) (0)
98 Clinical improvement after physical training is paralleled by decrease in plasma brain natriuretic peptide in heart failure patients (2004) (0)
Angina and positive exercise ECG are associated to a deeper impairment of coronary microcirculatory function and concentric LV remodeling in hypertensive patients without coronary artery disease. (2001) (0)
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy (2022) (0)
of the Power Spectral ardiovascular Ti Asses sing the Frequency epresentations (T ole of the Time (1996) (0)
401Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study (2018) (0)
Baroreflex sensitivity, assessed by a novel noninvasive method, holds prognostic value in systolic heart failure (2012) (0)
Effects of smoking in patients treated with cardiac resynchronization therapy (2012) (0)
314 Heat shock protein 72 in heart failure (2003) (0)
Cardiorenal scintigraphy with tetrofosmin in the evaluation of cardiorenal disease (2008) (0)
Sympathetic Reflex Response to Brachial Artery Occlusion (1996) (0)
Identification/quantification of distinct sub-components of serum gamma-glutamyltransferase (2007) (0)
1107 PLASMA CIRCULATING TRANSTHYRETIN FORMS IN PATIENTS WITH WILD TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS (2022) (0)
Myocardial interstitial remodelling in paucisymptomatic patients with initial dilated cardiomyopathy (2011) (0)
Recommendations for the clinical use of cardiac natriuretic peptides. (2005) (0)
Baroreflex activation therapy in heart failure: targeting the right patient (2022) (0)
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. (2022) (0)
66 Relative efficacy of sacubitril/valsartan, dapagliflozin and vericiguat: a systematic review and network meta-analysis (2020) (0)
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant. (2023) (0)
Evaluating biomarkers as predictors of cancer therapy cardiotoxicity: all you need is a meta‐analysis?. Letter regarding the article ‘Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta‐analysis.’ (2020) (0)
Caso clinico: cardiopatia in una portatrice di distrofia muscolare di Duchenne (2008) (0)
Possibile ruolo del fattore natriuretico atriale nel ripristino della risposta diuretica dopo ultrafiltrazione nella insufficienza cardiaca congestizia refrattaria (1989) (0)
Il respiro di Cheyne-Stokes in un paziente con scompenso cardiaco: implicazioni fisiopatologiche e cliniche (2009) (0)
Danno del microcircolo e disfunzione autonomica nella sclerosi sistemica (1997) (0)
Raccomandazioni sull'impiego clinico dei peptici natriuretici cardiaci (2005) (0)
La tolleranza allo sforzo è correlata direttamente con la riserva coronarica ed inversamente con la risposta di frequenza cardiaca e pressione arteriosa all’esercizio in pazienti ipertesi senza ischemia miocardica. (1999) (0)
Update sui biomarcatori nello scompenso cardiaco (2013) (0)
Alterazioni del microcircolo periferico cutaneo nella sclerosi sistemica: studio mediante flussimetria laser doppler (1999) (0)
G. Vergaro1, A. Valleggi1, L.E. Pastormerlo1, G. Mirizzi1, S. Chiappino1, R. Poletti1, L. Padeletti2, M. Emdin1, C. Passino3 (2011) (0)
Valutazione di un metodo di dosaggio del BNP nel sangue capillare (2013) (0)
Cartella clinica automatizzata per il reparto di cardiologia (1998) (0)
Ruolo della gamma-glutamiltransferasi quale fattore di rischio cardiovascolare (2006) (0)
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP (2012) (0)
Determinazione di NT-proBNP con metodo immunometrico elettrochemiluminescente (2003) (0)
Gamma-glutamiltransferasi: rivelazione e quantificazione di diverse forme di associazione dell’enzima nel plasma (2006) (0)
Nuovi strumenti di management per la gestione integrata dei percorsi assistenziali dei pazienti cronici (2018) (0)
Techinche di studio del sistema nervoso autonomo: i test di laboratorio. (2001) (0)
Forme molecolari dela gamma-glutammiltransferasi: caratteristiche e biogenesi (2012) (0)
Iperattività simpatica e prolungamento dell’intervallo QTc nell’ipertensone lieve di recente insorgenza (1999) (0)
Funzione endocrina cardiaca nello scompenso determinanti clinici, neuroormonali ed emodinamici (2006) (0)
Sacubitril/valsartan, una nuova ed efficace terapia dello scompenso cardiaco a funzione sistolica ridotta (2017) (0)
Reply (2021) (0)
Cardiomiopatia e ipereosinofilia: un caso post-partum (2009) (0)
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. (2001) (0)
Ruolo dei biomarcatori per la stratificazione prognostica e la personalizzazione del follow-up nel paziente con scompenso cardiaco (2010) (0)
Risposta riflessa simpatica all’occlusione dell’arteria brachiale (1997) (0)
Forme molecolari della gamma-glutammiltransferasi: caratteristiche e biogenesis. (2012) (0)
Gamma-glutamiltransferasi e prognosi cardiovascolare: rivelazione e caratterizzazione di diverse forme di associazione dell’enzima nel plasma (2006) (0)
Reply (2020) (0)
Ridotta vasodilatazione endotelio-dipendente ed indipendente del microcircolo periferico in pazienti con aterosclerosi coronarica (2000) (0)
Ridotta Tolleranza all'Esercizio in Donne Normotese e Ipertese senza Ischemia Miocardica: Relazione con la Risposta Emodinamica allo Sforzo (1995) (0)
Valutazione della miosina serica come indicatore di necrosi nell’infarto miocardico transmurale e nell’emorragia subaracnoidea (1993) (0)
Differente regolazione dei due sistemi principali dei peptidi natriuretici cardiaci (ANP e BNP) in pazienti con patologie cardiache acquisite e congenite (2009) (0)
Diminuita vasodilatazione endotelio-dipendente ed indipendente a livello del microcircolo periferico in pazienti con aterosclerosi coronarica (1999) (0)
Tecniche di studio del sistema nervoso autonomo: dinamica di segnale e tecniche diagnostiche d' immagine (2001) (0)
Andamento del tratto QTc nell’arco delle 24 ore in pazienti con ipertensione di grado lieve di recente insorgenza: relazione con l’iperattività simpatica (1999) (0)
Lo stress test elettrocardiografico dopo rivascolarizzazione miocardica: utilità, tempistica, modalità di esecuzione e confronto con altre procedure diagnostiche (2018) (0)
Riduzione della riserva coronarica ed aumento delle resistenze coronariche minime nell’ipertensione arteriosa borderline-live (1999) (0)
Relazione tra tolleranza allo sforzo e riserva coronarica in pazienti ipertesi essenziali senza aterosclerosi coronarica (2000) (0)
Alterazioni microcircolatorie nella sclerosi sistemica: studio mediante laser-doppler digitale (1999) (0)
Cardiomiopatia dilatativa familiare associata a miopatia (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michele Emdin?

Michele Emdin is affiliated with the following schools:

Michele Emdin's Academic­Influence.com Rankings

Michele Emdin's Degrees

Why Is Michele Emdin Influential?

Michele Emdin's Published Works

Published Works

What Schools Are Affiliated With Michele Emdin?

Michele Emdin's AcademicInfluence.com Rankings